imetelstat 47 MG Injection [Rytelo]
- RxCUI
- 2685246
- RxNorm name
- imetelstat 47 MG Injection [Rytelo]
- Display name
- imetelstat 47 MG Injection [Rytelo]
- Full name
- imetelstat 47 MG Injection [Rytelo]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RYTELO | IMETELSTAT SODIUM | Geron Corporation | b0fab7ca-e578-43c5-9df6-bdaff4182257 | 2026-04-22 | Warnings, Adverse reactions | 2685246 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b0fab7ca-e578-43c5-9df6-bdaff4182257 | RYTELO 47 MG Injection [PSN] · imetelstat 47 MG Injection [Rytelo] [SBD] · Rytelo 47 MG Injection [SY] | 3 | 4 | These highlights do not include all the information needed to use RYTELO safely and effectively. See full prescribing information for RYTELO. RYTELO ® (imetelstat) for injection, for intravenous use. Initial U.S. Approval: 2024 | 20260422 |